menu
    • menu

    Company profile for Umedica Laboratories

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    UMEDICA is a part of the Amoli Group of Companies, manufacturing and exporting a wide range of formulations viz; Injectables, Tablets, Capsules, Suspensions, Dry Syrups, etc. UMEDICA offers a diverse product portfolio comprising of antibiotics, non-steroidal anti-inflammatory (NSAIDs), analgesics, antifungal, antiviral, anti-malarials, antituberculosis agents, antihistaminics, psychotropic, antihypertensives, lipid-lowering ag...
    UMEDICA is a part of the Amoli Group of Companies, manufacturing and exporting a wide range of formulations viz; Injectables, Tablets, Capsules, Suspensions, Dry Syrups, etc. UMEDICA offers a diverse product portfolio comprising of antibiotics, non-steroidal anti-inflammatory (NSAIDs), analgesics, antifungal, antiviral, anti-malarials, antituberculosis agents, antihistaminics, psychotropic, antihypertensives, lipid-lowering agents, drugs for sexual dysfunction, multivitamins etc. UMEDICA's manufacturing facility, located in Vapi, Gujarat is a WHO GMP approved, US FDA, EU, Health Canada & TGA approved facility.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Umedica Laboratoriesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    302, Dalamal House, 3rd Floor, J. Bajaj Road, Nariman Point, Mumbai - 400 021
    Telephone
    Telephone
    +91 - 22 – 62455050
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.umedicalabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/umedica-labs
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/UmedicaLabs

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Umedica’s Generics Sertraline HCl Receives Approval in US
    Umedica’s Generics Sertraline HCl Receives Approval in US

    20 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218342

    FDA
    20 Jan 2026
    Share Share
    Umedica’s Generics Varenicline Tartrate Receives Approval in US
    Umedica’s Generics Varenicline Tartrate Receives Approval in US

    09 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218985

    FDA
    09 Jan 2026
    Share Share
    Umedica’s Generics Diclofenac Sodium Receives Approval in US
    Umedica’s Generics Diclofenac Sodium Receives Approval in US

    05 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219945

    FDA
    05 Nov 2025
    Share Share
    Umedica's Generic Carbamazepine Receives Approval in the U.S.
    Umedica's Generic Carbamazepine Receives Approval in the U.S.

    18 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216594

    FDA
    18 Aug 2022
    Share Share
    Umedica Lab`s Generic Diclofenac PotassiumReceives Approval In US
    Umedica Lab`s Generic Diclofenac PotassiumReceives Approval In US

    11 May 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215750

    FDA
    11 May 2022
    Share Share
    Umedica Lab`s Generic Sildenafil Citrate Receives Approval In US
    Umedica Lab`s Generic Sildenafil Citrate Receives Approval In US

    27 Aug 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209302

    FDA
    27 Aug 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search